Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Chromatography A

• Publication date

  2014-03-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chroma.2013.11.057PMID 24365115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Performing native mass spectrometry analysis on therapeutic antibodies.

  2014cited by this paper
• Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometry

  2013cited by this paper
• Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals

  2013cited by this paper
• Critical evaluation of fast size exclusion chromatographic separations of protein aggregates, applying sub-2 μm particles.

  2013cited by this paper
• Analytical lessons learned from selected therapeutic protein drug comparability studies.

  2013cited by this paper
• Nondenaturing size-exclusion chromatography-mass spectrometry to measure stress-induced aggregation in a complex mixture of monoclonal antibodies.

  2013cited by this paper
• Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation.

  2013cited by this paper
• Characterization of monoclonal antibody size variants containing extra light chains

  2013cited by this paper
• Ion mobility-mass spectrometry of complex carbohydrates: collision cross sections of sodiated N-linked glycans.

  2013cited by this paper
• Recent trends in analytical and structural glycobiology.

  2013cited by this paper
• Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-Fourier transform ion cyclotron resonance-mass spectrometry.

  2013cited by this paper
• Epitope mapping of antibodies by mass spectroscopy: a case study.

  2013cited by this paper
• Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry

  2013cited by this paper
• Disulfide bond assignment of an IgG1 monoclonal antibody by LC-MS with post-column partial reduction.

  2013cited by this paper
• An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture.

  2013cited by this paper
• A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance.

  2013cited by this paper
• Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

  2013cited by this paper
• Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS.

  2013cited by this paper
• Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule

  2013cited by this paper
• Top-down characterization of biopharmaceuticals

  2013cited by this paper
• A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics.

  2013cited by this paper
• Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor.

  2013cited by this paper
• Analytical and bioanalytical technologies for characterizing antibody-drug conjugates.

  2013cited by this paper
• Improving pH gradient cation-exchange chromatography of monoclonal antibodies by controlling ionic strength.

  2013cited by this paper
• Automated, high-throughput IgG-antibody glycoprofiling platform.

  2013cited by this paper
• Analytical characterization of biosimilar antibodies and Fc-fusion proteins

  2013cited by this paper
• Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method.

  2013cited by this paper
• Analytical strategies for the characterization of therapeutic monoclonal antibodies

  2013cited by this paper
• Characterization of therapeutic antibodies and related products.

  2013cited by this paper
• Development of a native nanoelectrospray mass spectrometry method for determination of the drug-to-antibody ratio of antibody-drug conjugates.

  2013cited by this paper
• Simultaneous analysis of the non-canonical amino acids norleucine and norvaline in biopharmaceutical-related fermentation processes by a new ultra-high performance liquid chromatography approach

  2013cited by this paper
• Kinetic evaluation of new generation of column packed with 1.3 μm core-shell particles.

  2013cited by this paper
• High-sensitivity analytical approaches for the structural characterization of glycoproteins.

  2013cited by this paper
• An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins.

  2013cited by this paper
• Therapeutic antibodies: market considerations, disease targets and bioprocessing.

  2013cited by this paper
• Conformational analysis of recombinant monoclonal antibodies with hydrogen/deuterium exchange mass spectrometry.

  2013cited by this paper
• Monoclonal antibody heterogeneity analysis and deamidation monitoring with high-performance cation-exchange chromatofocusing using simple, two component buffer systems.

  2013cited by this paper
• Analytical aspects of biosimilarity issues of protein drugs.

  2012cited by this paper
• Using Hydrogen/Deuterium Exchange Mass Spectrometry to Study Conformational Changes in Granulocyte Colony Stimulating Factor upon PEGylation

  2012cited by this paper
• Size-exclusion chromatography with multi-angle light scattering for elucidating protein aggregation mechanisms.

  2012cited by this paper
• Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach

  2012cited by this paper
• New trends in reversed-phase liquid chromatographic separations of therapeutic peptides and proteins: theory and applications.

  2012cited by this paper
• Capillary size exclusion chromatography with picogram sensitivity for analysis of monoclonal antibodies purified from harvested cell culture fluid.

  2012cited by this paper
• Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking

  2012cited by this paper
• Which are the antibodies to watch in 2012?

  2012cited by this paper
• Effective use of mass spectrometry for glycan and glycopeptide structural analysis.

  2012cited by this paper
• General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies.

  2012cited by this paper
• Electrochemistry-assisted top-down characterization of disulfide-containing proteins.

  2012cited by this paper
• Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS.

  2012cited by this paper
• Marketed therapeutic antibodies compendium

  2012cited by this paper
• Determination of deamidation artifacts introduced by sample preparation using 18O-labeling and tandem mass spectrometry analysis.

  2012cited by this paper
• Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.

  2012cited by this paper
• Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography.

  2012cited by this paper
• MALDI-MS/MS with Traveling Wave Ion Mobility for the Structural Analysis of N-Linked Glycans

  2012cited by this paper
• Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

  2012cited by this paper
• What's fueling the biotech engine—2011 to 2012

  2012cited by this paper
• Analysis of Intact Monoclonal Antibody IgG1 by Electron Transfer Dissociation Orbitrap FTMS*

  2012cited by this paper
• Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry.

  2012cited by this paper
• Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

  2012cited by this paper
• Analysis of recombinant monoclonal antibodies by RPLC: toward a generic method development approach.

  2012cited by this paper
• Mass transfer kinetics, band broadening and column efficiency.

  2012cited by this paper
• A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies.

  2012cited by this paper
• On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.

  2012cited by this paper
• Development of capillary size exclusion chromatography for the analysis of monoclonal antibody fragments extracted from human vitreous humor.

  2012cited by this paper
• Use of CID/ETD Mass Spectrometry to Analyze Glycopeptides

  2012cited by this paper
• Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.

  2012cited by this paper
• Qualitative and semiquantitative analysis of composite mixtures of antibodies by native mass spectrometry.

  2012cited by this paper
• Automatic disulfide bond assignment using a1 ion screening by mass spectrometry for structural characterization of protein pharmaceuticals.

  2012cited by this paper
• A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.

  2012cited by this paper
• Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody.

  2012cited by this paper
• Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1

  2012cited by this paper
• Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

  2012cited by this paper
• Electrospray-differential mobility analysis as an orthogonal tool to size-exclusion chromatography for characterization of protein aggregates.

  2012cited by this paper
• Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.

  2012cited by this paper
• Monoclonal antibody therapeutics: history and future.

  2012cited by this paper
• Elucidation of Degradants in Acidic Peak of Cation Exchange Chromatography in an IgG1 Monoclonal Antibody Formed on Long-Term Storage in a Liquid Formulation

  2011cited by this paper
• HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region.

  2011cited by this paper
• Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody.

  2011cited by this paper
• Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry.

  2011cited by this paper
• Separation of oxidized variants of a monoclonal antibody by anion-exchange.

  2011cited by this paper
• A sub-two minutes method for monoclonal antibody-aggregate quantification using parallel interlaced size exclusion high performance liquid chromatography.

  2011cited by this paper
• What's fueling the biotech engine--2010 to 2011.

  2011cited by this paper
• Validation of a pH gradient-based ion-exchange chromatography method for high-resolution monoclonal antibody charge variant separations.

  2011cited by this paper
• Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies

  2011cited by this paper
• Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose

  2011cited by this paper
• Analysis of glycans derived from glycoconjugates by capillary electrophoresis‐mass spectrometry

  2011cited by this paper
• Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation.

  2011cited by this paper
• Identification of N-glycans displaying mannose-6-phosphate and their site of attachment on therapeutic enzymes for lysosomal storage disorder treatment.

  2011cited by this paper
• Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis.

  2011cited by this paper
• Characterization of glycoprotein digests with hydrophilic interaction chromatography and mass spectrometry.

  2011cited by this paper
• Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.

  2011cited by this paper
• Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products.

  2011cited by this paper
• The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

  2011cited by this paper
• Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry.

  2011cited by this paper
• Fragmentation of monoclonal antibodies

  2011cited by this paper
• Analytical methods for physicochemical characterization of antibody drug conjugates

  2011cited by this paper
• Analytical characterization of a novel degradation product in a PEGylated recombinant protein.

  2011cited by this paper
• Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.

  2011cited by this paper
• Acceptable changes in quality attributes of glycosylated biopharmaceuticals

  2011cited by this paper
• Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer

  2011cited by this paper

• Impact of Supercharging on Top-Down Characterization of Monoclonal Antibodies by Collision Induced Dissociation

  2026cites this paper
• Advances in molecularly imprinted polymers for clinical biomarker detection (2021–2025)

  2025cites this paper
• Two-Dimensional Liquid Chromatography Applications in Biopharmaceutical Analysis

  2025cites this paper
• Molecular diffusion of biomolecules: a database for representative model biomolecules in reversed-phase liquid chromatography conditions.

  2025cites this paper
• Rapid High Performance Liquid Chromatography methodologies for analytical characterization of biotherapeutic products

  2025cites this paper
• Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS

  2025cites this paper
• The Hidden Influence: Impacts of Residual Dimethylformamide in NDSB‐211 on icIEF Separation for Monoclonal Antibodies

  2025cites this paper
• Comprehensive characterization of bacterial glycoconjugate vaccines by liquid chromatography - mass spectrometry.

  2024cites this paper
• Isolation and characterization of rabies monoclonal antibody charge variants

  2024cites this paper
• Identification of structural origins of complex charge heterogeneity in therapeutic ACE2Fc fusion protein facilitated by free-flow isoelectric focusing.

  2024cites this paper
• Multidimensional LC-MS with 1D multi-method option and parallel middle-up and bottom-up MS acquisition for in-depth characterization of antibodies.

  2024cites this paper
• Detailed Glycosylation Analysis of Therapeutic Enzymes Using Comprehensive 2D-LC–MS

  2024cites this paper
• Exploring the Correlation between LC–MS Multi-Attribute Method and Conventional Chromatographic Product Quality Assays through Multivariate Data Analysis

  2024cites this paper
• Chromatographic properties of deamidated peptides with Asn-Gly sequences in proteomic bottom-up experiments.

  2024cites this paper
• 2D-CEX-FcRn-MS to Study Structure/Function Relation of mAb Charge Variants.

  2024cites this paper
• The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning

  2024cites this paper
• Rapid identification of antibody impurities in size-based electrophoresis via CZE-MS generated spectral library

  2024cites this paper
• Characterizing Non-covalent Protein Complexes Using Asymmetrical Flow Field-Flow Fractionation On-Line Coupled to Native Mass Spectrometry

  2023cites this paper
• Comparative Analysis of Glycoform Profiles Between Biosimilar and Originator Monoclonal Antibodies by Liquid Chromatography–Mass Spectrometry

  2023cites this paper
• Proteomics Techniques in Focus: From Basics to Advanced Applications

  2023cites this paper
• Characterization of mAb size heterogeneity originating from a cysteine to tyrosine substitution using denaturing and native LC-MS.

  2023cites this paper
• What is the role of current mass spectrometry in pharmaceutical analysis?

  2023cites this paper
• Method validation and new peak detection for the liquid chromatography-mass spectrometry multi-attribute method.

  2023cites this paper
• Theoretical charge plots as a tool for targeted and accelerated ion exchange chromatography method development of NANOBODYⓇ molecules.

  2023cites this paper
• Identification, characterization, and engineering of glycosylation in thrombolyticsa.

  2023cites this paper
• Revealing charge heterogeneity of stressed trastuzumab at the subunit level

  2023cites this paper
• Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS.

  2022cites this paper
• Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals

  2022cites this paper
• Comprehensive Multidimensional Liquid Chromatography–Mass Spectrometry for the Characterization of Charge Variants of a Bispecific Antibody

  2022cites this paper
• Molecular Size-Selective Electrodialytic Desalters for Electrospray Ionization-Mass Spectrometry.

  2022cites this paper
• Rapid label-free cell-based Approach Membrane Permeability Assay using MALDI-hydrogen-deuterium exchange mass spectrometry for peptides.

  2022cites this paper
• Comparison of originator and biosimilar monoclonal antibodies using HRMS, Fc affinity chromatography, and 2D-HPLC

  2022cites this paper
• Implementing 1.5 mm internal diameter columns into analytical workflows.

  2022cites this paper
• Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: a 20-year follow-up study of originators and biosimilars.

  2022cites this paper
• 3D-LC-MS with 2D Multimethod Option for Fully Automated Assessment of Multiple Attributes of Monoclonal Antibodies Directly from Cell Culture Supernatants.

  2022cites this paper
• Liquid phase separation techniques for the characterization of monoclonal antibodies and bioconjugates

  2022cites this paper
• Multi-attribute method performance profile for quality control of monoclonal antibody therapeutics.

  2021cites this paper
• Analytical tools for the characterization of deamidation in monoclonal antibodies

  2021cites this paper
• Improvement of the Degradation Profiling of Eculizumab and Omalizumab Monoclonal Antibodies by Liquid Chromatography–Mass Spectrometry

  2021cites this paper
• Monolithic Papain-Immobilized Enzyme Reactors for Automated Structural Characterization of Monoclonal Antibodies

  2021cites this paper
• Analytical Techniques to Study Carbohydrates

  2021cites this paper
• Size exclusion chromatography for the characterization and quality control of biologics

  2021cites this paper
• Enhancing the multi-attribute method through an automated and high-throughput sample preparation

  2021cites this paper
• Inline electrochemical reduction of NISTmAb for middle-up subunit liquid chromatography-mass spectrometry analysis.

  2021cites this paper
• Recent biopharmaceutical applications of capillary electrophoresis methods on recombinant DNA technology‐based products

  2021cites this paper
• High-Resolution Native Mass Spectrometry

  2021cites this paper
• Monoclonal antibody charge variant characterization by fully automated four-dimensional liquid chromatography-mass spectrometry.

  2021cites this paper
• Evaluation of strategies for overcoming trifluoroacetic acid ionization suppression resulted in single-column intact level, middle-up, and bottom-up reversed-phase LC-MS analyses of antibody biopharmaceuticals.

  2021cites this paper
• Multidimensional chromatography platforms: status and prospects.

  2021cites this paper
• At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization

  2021cites this paper
• Exploring the Chemical Space of Protein Glycosylation in Noncovalent Protein Complexes: An Expedition along Different Structural Levels of Human Chorionic Gonadotropin by Employing Mass Spectrometry.

  2021cites this paper
• Process development of recombinant Aspergillus flavus urate oxidase production in Pichia pastoris intracellularly and its characterization as a potential biosimilar

  2021cites this paper
• Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs.

  2021cites this paper
• Application of a High-Throughput Microfermentation System for the Screening of Protein Refolding

  2021cites this paper
• Separation methods hyphenated to mass spectrometry for the characterization of the protein glycosylation at the intact level.

  2020cites this paper
• A proteolytic nanobiocatalyst with built-in disulphide reducing properties

  2020cites this paper
• Evaluation of particle and bed integrity of aqueous size-exclusion columns packed with sub-2 µm particles operated at high pressure.

  2020cites this paper
• Characterizing and Quantitating Therapeutic Tethered Multimeric Antibody Degradation Using Affinity Capture Mass Spectrometry.

  2020cites this paper
• Synthesis and characterization of (R)-phenylephrine bonded non-porous polystyrene-divinylbenzene for fast separation of proteins by mixed-mode liquid chromatography

  2020cites this paper
• Robust Analytical Methods for the Accurate Quantification of the Total Biomass Composition of Mammalian Cells.

  2020cites this paper
• Chromatography (other than size-exclusion chromatography) and electrophoresis

  2020cites this paper
• Trends in the Analysis of Biopharmaceuticals by HPLC

  2020cites this paper
• Middle-up characterization of monoclonal antibodies by online reduction liquid chromatography-mass spectrometry.

  2020cites this paper
• Direct seminal fluid identification by protease‐free high‐resolution mass spectrometry

  2020cites this paper
• Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute Method.

  2020cites this paper
• Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing.

  2020cites this paper
• Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies

  2020cites this paper
• Development of a generic reversed-phase liquid chromatography method for protein quantification using analytical quality-by-design principles.

  2020cites this paper
• Liposome Artificial Membrane Permeability Assay by MALDI-hydrogen-deuterium exchange mass spectrometry for peptides and small proteins.

  2020cites this paper
• Use of Raman spectroscopy and size-exclusion chromatography coupled with HDX-MS spectroscopy for studying conformational changes of small proteins in solution.

  2020cites this paper
• Isobaric Tandem Mass Tag Multiplexed Post-Translational Modification Quantitation of Biopharmaceuticals by Targeted High Resolution Mass Spectrometry.

  2020cites this paper
• Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates

  2020cites this paper
• Simple Addition of Glycine in Trifluoroacetic Acid-containing Mobile Phases Enhances the Sensitivity of Electrospray Ionization Mass Spectrometry for Biopharmaceutical Characterization.

  2020cites this paper
• Biotherapeutic Products, Cellular Factories, and Multiomics Integration in Metabolic Engineering

  2020cites this paper
• Bottom-up sample preparation for the LC-MS/MS quantification of anti-cancer monoclonal antibodies in bio matrices.

  2020cites this paper
• Mass Spectrometry‐Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization (OptimAbs)

  2020cites this paper
• Top-Down Characterization of an Intact Monoclonal Antibody using Activated Ion-Electron Transfer Dissociation.

  2020cites this paper
• Development and application of two-dimensional separation systems coupled to mass spectrometry incorporating capillary electrophoresis

  2019cites this paper
• Hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs and therapeutic peptides: A review based on the separation characteristics of the hydrophilic interaction chromatography phases.

  2019cites this paper
• A generic workflow for the characterization of therapeutic monoclonal antibodies—application to daratumumab

  2019cites this paper
• Intact protein bioanalysis by liquid chromatography - High-resolution mass spectrometry

  2019cites this paper
• Characterization of erythropoietin biosimilars using mass spectrometric CID and HCD techniques

  2019cites this paper
• First profiling in hydrophilic interaction liquid chromatography of intact human chorionic gonadotropin isoforms.

  2019cites this paper
• Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.

  2019influential citation
• Chromatographic tools for plant-derived recombinant antibodies purification and characterization.

  2019cites this paper
• Implementation of a High-Resolution LC/MS Method in Quality Control Laboratories for Release and Stability Testing of a Commercial Antibody Product.

  2019cites this paper
• Intact protein bioanalysis by liquid chromatography - High-resolution mass spectrometry.

  2019cites this paper
• Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against Mycobacterium tuberculosis

  2018cites this paper
• Heterogeneity assessment of antibody-derived therapeutics at the intact and middle-up level by low-flow sheathless capillary electrophoresis-mass spectrometry.

  2018cites this paper
• Identification and quantification of product-related quality attributes in bio-therapeutic monoclonal antibody via a simple, and robust cation-exchange HPLC method compatible with direct online detection of UV and native ESI-QTOF-MS analysis.

  2018cites this paper
• Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic Monoclonal Antibodies Using Strong Cation Exchange Chromatography Coupled to Native Mass Spectrometry.

  2018cites this paper
• Stratégies chromatographiques en phase liquide et supercritique pour l'analyse de candidats médicaments

  2018cites this paper
• Use of high-throughput tools to optimise polishing-chromatography sequences for complex feed mixtures

  2018cites this paper
• Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals

  2018cites this paper
• Performance of Optimized Wide Pore Superficially Porous Particles for Separation of Proteins and Immunoglobulin G Antibodies.

  2018cites this paper
• Identification of N-Terminally Truncated Derivatives of Insulin Analogs Formed in Pharmaceutical Formulations

  2018cites this paper
• Proteins and antibodies in serum, plasma, and whole blood—size characterization using asymmetrical flow field-flow fractionation (AF4)

  2018cites this paper
• Stepwise “bridge‐to‐bridge” reduction of monoclonal antibodies and light chain detection: Case studies of tenatumomab and trastuzumab

  2018cites this paper
• Improving Mass Spectral Quality of Monoclonal Antibody Middle-Up LC-MS Analysis by Shifting the Protein Charge State Distribution.

  2018cites this paper
• Development and validation of a (RP)UHPLC‐UV‐(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column

  2018cites this paper